Business Description
THC Farmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US87243T1007
Compare
Compare
Traded in other countries / regions
CBDG.USA IPO Date
2012-08-22Description
THC Farmaceuticals Inc is a clinical stage biotechnology company. It specializes in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and various other medical disciplines.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.64 | |||||
| 9-Day RSI | 24.56 | |||||
| 14-Day RSI | 33.58 | |||||
| 6-1 Month Momentum % | -53.86 | |||||
| 12-1 Month Momentum % | 64.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -316.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| EV-to-EBIT | -24 | |||||
| EV-to-EBITDA | -32 | |||||
| EV-to-Revenue | 16 | |||||
| Earnings Yield (Greenblatt) % | -4.17 | |||||
| FCF Yield % | -19.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CBDG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
THC Farmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.006 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | -15.37 | ||
| Volatility % | 333.53 | ||
| 14-Day RSI | 33.58 | ||
| 14-Day ATR ($) | 0.000749 | ||
| 20-Day SMA ($) | 0.005975 | ||
| 12-1 Month Momentum % | 64.17 | ||
| 52-Week Range ($) | 0.0002 - 0.094 | ||
| Shares Outstanding (Mil) | 18.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
THC Farmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
THC Farmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
THC Farmaceuticals Inc Frequently Asked Questions
What is THC Farmaceuticals Inc(CBDG)'s stock price today?
The current price of CBDG is $0.01. The 52 week high of CBDG is $0.09 and 52 week low is $0.00.
When is next earnings date of THC Farmaceuticals Inc(CBDG)?
The next earnings date of THC Farmaceuticals Inc(CBDG) is .
Does THC Farmaceuticals Inc(CBDG) pay dividends? If so, how much?
THC Farmaceuticals Inc(CBDG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers